WAVELENGTH ENTERPRISES LTD

Overview

WAVELENGTH ENTERPRISES LTD is an active pharmaceutical ingredient (API) supplier with 34 active FDA Type II Drug Master Files, covering CETIRIZINE DIHYDROCHLORIDE; CILOSTAZOL; CISATRACURIUM BESYLATE; CISATRACURIUM BESYLATE PROCESS B; CLASCOTERONE; DONEPEZIL HYDROCHLORIDE FORM III.

API / Drug Master Files

WAVELENGTH ENTERPRISES LTD holds 34 active (37 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• CLASCOTERONEActive2024-06-06
• SITAGLIPTIN PHOSPHATE MONOHYDRATEActive2024-02-02
• CISATRACURIUM BESYLATE PROCESS BActive2024-01-29
• PRALIDOXIME CHLORIDEActive2022-06-14
• CETIRIZINE DIHYDROCHLORIDEActive2021-01-24
• SUGAMMADEX SODIUMActive2020-11-03
• TAVABOROLEActive2017-12-31
• PERMETHRINActive2016-12-29
• IBRUTINIBActive2016-08-16
• EFINACONAZOLEActive2016-05-31
• FULVESTRANTActive2015-06-28
• PRAMIPEXOLE BASEActive2015-01-11
• FLUTICASONE FUROATEActive2014-09-30
• TIOTROPIUM BROMIDE MONOHYDRATEActive2013-12-26
• ROTIGOTINEActive2012-07-12

Showing 15 of 37 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to WAVELENGTH ENTERPRISES LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.